Search

Your search keyword '"Fernando F. Gonzalez"' showing total 79 results

Search Constraints

Start Over You searched for: Author "Fernando F. Gonzalez" Remove constraint Author: "Fernando F. Gonzalez" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
79 results on '"Fernando F. Gonzalez"'

Search Results

1. How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?

2. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo

3. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns

5. Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey

6. Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease.

7. Plasma brain-derived tau correlates with cerebral infarct volume.

8. Synthesis and characterization of NiAl-hydride heterometallics: perturbing electron density within Al-H-Ni subunits.

9. Toward a common interpretation of the 3Rs principles in animal research.

10. Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25 + CD163 + CD206 + macrophages.

11. Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.

12. The role of astrocytes in depression, its prevention, and treatment by targeting astroglial gliotransmitter release.

13. Introducing the COST Action 'Improving the Quality of Biomedical Science with 3Rs Concepts' (IMPROVE).

14. Transradial approach for middle meningeal artery embolization is a safe alternative to transfemoral approach in patients with chronic subdural hematoma: A single-center retrospective comparative study.

15. Plasma phosphorylated-tau217 is increased in Niemann-Pick disease type C.

16. Neuronal plasma biomarkers in acute ischemic stroke.

17. Special Operations Medical Association Training, Education & Scientific Assembly 2024: Recognized Research Track Abstracts.

18. Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.

19. Cost Savings on Inpatient Hospitalization for Middle Meningeal Artery Embolization in the Setting of Increased Case Volume and Low Complications Rate.

20. A Cross-Sectional Review of HIV Screening in High-Acuity Emergency Department Patients: A Missed Opportunity.

21. Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke.

22. The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.

23. Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies.

24. The Role of Psychological Factors in Noncardiac Chest Pain of Esophageal Origin.

25. Analysis of unknown (unlabeled/mislabeled) drug products for active pharmaceutical ingredients and related substances by an international mail facility satellite laboratory equipped with rapid screening devices.

26. Pretreatment CTP Collateral Parameters Predict Good Outcomes in Successfully Recanalized Middle Cerebral Artery Distal Medium Vessel Occlusions.

27. Clinically Asymptomatic Hemorrhagic Conversion Is Associated with Need for Inpatient Rehabilitation After Mechanical Thrombectomy for Anterior Circulation Ischemic Stroke.

28. Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adults.

29. Relationship of Neonatal Seizure Burden Before Treatment and Response to Initial Antiseizure Medication.

30. Most Promising Approaches to Improve Brain AVM Management: ARISE I Consensus Recommendations.

31. Esophageal Versus Rectal Temperature Monitoring During Whole-Body Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: Association with Short- and Long-Term Outcomes.

32. A 3D-Printed Dummy for Training Distal Phalanx Amputation in Mice.

33. Performance of long-wave infrared band of microstructured heavily doped InAsSb on type II superlattice layer part 1: the photonic study.

34. Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.

35. Donors with repeated blood product discards for filtration problems, clots or hemolysis: Causes and follow-up.

36. Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217.

37. Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series).

38. Association of Plasma Brain-Derived Tau With Functional Outcome After Ischemic Stroke.

39. Development and evaluation of ciprofloxacin local controlled release materials based on molecularly imprinted polymers.

40. Asperger's syndrome - about time to rename it?

41. A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.

42. Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy.

43. Pretreatment CT perfusion collateral parameters correlate with penumbra salvage in middle cerebral artery occlusion.

44. Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.

45. Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease.

46. Heterozygous Knockout of ARID4B Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line.

47. Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.

48. Living donor robotic-assisted kidney transplant compared to traditional living donor open kidney transplant. Where do we stand now? A systematic review and meta-analysis.

49. The Compensation Index Is Better Associated with DSA ASITN Collateral Score Compared to the Cerebral Blood Volume Index and Hypoperfusion Intensity Ratio.

50. Brain-derived Tau for Monitoring Brain Injury in Acute Ischemic Stroke.

Catalog

Books, media, physical & digital resources